TD Cowen analyst Tyler Van Buren reiterated a Buy rating on Immunome Inc. (NASDAQ: IMNM).The analyst commented, "Immunome has been ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE